Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2024-06-03 00:00:00 ET · period of report 2024-05-30 · accession 0000950170-24-068013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-03 | 2024-05-30 | CRBP | Ben Yong | Dir | A - Grant | $0.00 | +2,783 | 2,783 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2024-05-30 | A | A | 2,783 | $0.00 | 2,783 | D | — | — | (F1) On May 30, 2024, 2,783 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant. |